The highly sustainable building will house a
Good Manufacturing Practice (GMP) health
development facility to support the creation
and testing of cutting-edge consumer health
innovations.
A suite of new laboratories will enable
healthcare scientists to carry out formulation
optimisation at the bench. New facilities for
analytical and microbiology teams housing
the latest equipment, which will allow them
to provide supportive data during both the
product development and stability phases.
New stability testing suites, one of the largest
in Europe, will enable better performance
evaluation of development products up to 3
years after manufacture.
A large Pilot Plant facility will complement
this allowing scale up studies, 1/10 scale
manufacturing for regulatory submissions
and preparation of clinical trial material.

The centre comprises:-
– Pilot Plant
– Stability
– Analytical, Microbiology, Formulation
and IMSU Laboratories
– Offices, Informal Meeting Spaces
– Mixed Use Atrium Space
– Kitchen and Restaurant Facilities
– Security Gatehouse and Services
Building
– Loading Bay and Small High Density
Storage Area.
Role and
Responsibility
Architecture, Laboratory Planning, Interior
and Landscape Design Services. RIBA
Stages 3-7.